Mapping the pathophysiology of schizophrenia: interactions between multiple cellular pathways

Mapping the pathophysiology of schizophrenia: interactions between multiple cellular pathways

Bibliographic Details
Main Authors:	Chao eDeng, Brian eDean
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2013-11-01
Series:	Frontiers in Cellular Neuroscience
Subjects:	Acetylcholine Cannabis Dopamine Schizophrenia BDNF GABA
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fncel.2013.00238/full

Similar Items

Cholinergic connectivity: it’s implications for psychiatric disorders.
by: Elizabeth eScarr, et al.
Published: (2013-05-01)

The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue.
by: Ralf eBrisch, et al.
Published: (2014-05-01)

Editorial: Mapping the pathophysiology of schizophrenia: interactions between multiple cellular pathways, volume II
by: Natalie Matosin, et al.
Published: (2023-06-01)

Biomarker Investigations Related to Pathophysiological Pathways in Schizophrenia and Psychosis
by: Gursharan eChana, et al.
Published: (2013-06-01)

Impact of structural aberrancy of polysialic acid and its synthetic enzyme ST8SIA2 in schizophrenia
by: Chihiro eSato, et al.
Published: (2013-05-01)

The Effects of Statins on Neurotransmission and Their Neuroprotective Role in Neurological and Psychiatric Disorders
by: Michał Kosowski, et al.
Published: (2021-05-01)

In silico investigation on the probable macromolecular drug targets involved in the anti-schizophrenia activity of Nardostachys jatamansi
by: Foong Xi Wei, et al.
Published: (2022-08-01)

Implications of SNP-triggered miRNA dysregulation in Schizophrenia development
by: Fadumo Abdullahi Mohamed, et al.
Published: (2024-01-01)

The Role of Dopamine D3 Receptors, Dysbindin, and Their Functional Interaction in the Expression of Key Genes for Neuroplasticity and Neuroinflammation in the Mouse Brain
by: Veronica Rivi, et al.
Published: (2023-05-01)

ErbB1-4-dependent EGF/neuregulin signals and their cross talk in the central nervous system: pathological implications in schizophrenia and Parkinson’s disease
by: Yuriko eIwakura, et al.
Published: (2013-02-01)

PE11 (Rv1169c) Selectively Altering Fatty Acid Components of Mycobacterium smegmatis and Host interleukin-6 Level Accompany with Cell Death
by: Wanyan eDeng
Published: (2015-06-01)

Limbic system associated membrane protein as a potential target for neuropsychiatric disorders
by: Eero eVasar, et al.
Published: (2013-03-01)

Cannabis use and abuse correlates in a homogenous South African schizophrenia population
by: Liezl Koen, et al.
Published: (2009-03-01)

Thyroid hormone-dependent development of early cortical networks: Temporal specificity and the contribution of trkB and mTOR pathways
by: Sören eWesterholz, et al.
Published: (2013-08-01)

Associations of BDNF/BDNF-AS SNPs with Depression, Schizophrenia, and Bipolar Disorder
by: Anton Shkundin, et al.
Published: (2023-09-01)

Zebrafish Get Connected: Investigating Neurotransmission Targets and Alterations in Chemical Toxicity
by: Katharine A. Horzmann, et al.
Published: (2016-08-01)

Research progress of the dopaminergic and cholinergic signaling pathways in myopia
by: Xiao-Ling Xiang, et al.
Published: (2022-09-01)

Cannabis use and cognitive impairment in schizophrenia
by: M. Gonçalves, et al.
Published: (2022-06-01)

Schizophrenia and visual backward masking: a general deficit of target enhancement
by: Michael H Herzog, et al.
Published: (2013-05-01)

cAMP Response Element-Binding Protein (CREB): A Possible Signaling Molecule Link in the Pathophysiology of Schizophrenia
by: Haitao Wang, et al.
Published: (2018-08-01)

Auditory mismatch responses are differentially sensitive to changes in muscarinic acetylcholine versus dopamine receptor function
by: Lilian Aline Weber, et al.
Published: (2022-05-01)

Possible mechanism of schizophrenia origin by excess GABA and synaptic pruning
by: A. Rabinovitch, et al.
Published: (2023-12-01)

Decreased Brain pH and Pathophysiology in Schizophrenia
by: Hae-Jeong Park, et al.
Published: (2021-08-01)

Acceptance of pharmaceutical cannabis substitution by cannabis using patients with schizophrenia
by: Jan van Amsterdam, et al.
Published: (2018-09-01)

Schizophrenia : Current concepts in aetiology
by: P S Bhat, et al.
Published: (2014-01-01)

Cannabis-induced psychosis masquerading schizophrenia or vice-versa? A diagnostic dilemma
by: Rachit Sharma, et al.
Published: (2021-01-01)

The Tumor Cytosol miRNAs, Fluid miRNAs and Exosome miRNAs in Lung Cancer
by: Xin eQin, et al.
Published: (2015-01-01)

Transdifferentiation of Human Circulating Monocytes Into Neuronal-Like Cells in 20 Days and Without Reprograming
by: Alfredo Bellon, et al.
Published: (2018-09-01)

Relationship between cannabis use and schizophrenia
by: J.J. Vazquez Vazquez, et al.
Published: (2022-06-01)

Microglial intracellular Ca2+ signaling as a target of antipsychotic actions for the treatment of schizophrenia
by: Yoshito eMizoguchi, et al.
Published: (2014-11-01)

ASPECTS OF CYCLON AND BDNF GENE EXPRESSION IN SCHIZOPHRENIA PATIENTS
by: Rinaldo Shishkov, et al.
Published: (2012-08-01)

Mechanisms for multiple activity modes of VTA dopamine neurons
by: Andrew eOster, et al.
Published: (2015-07-01)

Structural and Functional Deviations of the Hippocampus in Schizophrenia and Schizophrenia Animal Models
by: David Wegrzyn, et al.
Published: (2022-05-01)

Editorial: New Developments With Magnetoelectrical Techniques in Schizophrenia
by: Vicente Molina, et al.
Published: (2021-08-01)

The Effects of a Pilot Intervention for Community-Dwelling Adults with Rheumatoid Arthritis in Wuhan, China
by: Wenfang eDeng, et al.
Published: (2013-10-01)

ProBDNF and Brain-Derived Neurotrophic Factor Prodomain Differently Modulate Acetylcholine Release in Regenerating and Mature Mouse Motor Synapses
by: Polina O. Bogacheva, et al.
Published: (2022-05-01)

Oxidative Stress and the Pathophysiology and Symptom Profile of Schizophrenia Spectrum Disorders
by: Alex J. Murray, et al.
Published: (2021-07-01)

Acetylcholine induces GABA release onto rod bipolar cells through heteromeric nicotinic receptors expressed in A17 amacrine cells.
by: Claudio eElgueta, et al.
Published: (2015-02-01)

Cannabis and schizophrenia spectrum disorders: A review of clinical studies
by: Rodrigo Chaturaka, et al.
Published: (2009-01-01)

Role of the locus coeruleus and basal forebrain in arousal and attention
by: Eden B. Maness, et al.
Published: (2022-10-01)